Brief: AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Corporate Update
14/11/2022 21:45
Nov 14 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS INC Q3 SALES ROSE 217 PERCENT TO
$500,000
* ACELRX PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ACELRX PHARMACEUTICALS INC - $20.9 MILLION IN CASH AND
SHORT-TERM INVESTMENTS AS OF SEPTEMBER 30, 2022
* ACELRX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.94
Source text for Eikon: ID:nPnc2dwKKa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial